Article
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
American journal of hematology - 1 Aug 2024
Bewersdorf Jan Philipp, Shimony Shai, Shallis Rory M, Liu Yiwen, Berton Guillaume, Schaefer Eva J, Zeidan Amer M, Goldberg Aaron, Stein Eytan, Marcucci Guido, Bystrom Rebecca P, Lindsley R Coleman, Chen Evan C, Ramos Jorge, Stein Anthony, Pullarkat Vinod, Aldoss Ibrahim, DeAngelo Daniel J, Neuberg Donna S, Stone Richard M, Garciaz Sylvain, Ball Brian, Stahl Maximilian
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.